Pharmaceutical Science cmte. heads down “Critical Path”
Executive Summary
FDA's Advisory Committee for Pharmaceutical Science will discuss "Critical Path" initiative research opportunities on the first day if its Oct. 19-20 meeting. On Oct. 20, the committee will discuss implementation of the risk-based GMP initiative and generic drug equivalence issues. The meeting will be held at the CDER Advisory Committee conference room, 5630 Fishers Lane in Rockville, Md. beginning at 8:30 a.m. both days. [Editor's Note: To 1watch a webcast or order a video/DVD of this meeting, visit FDAAdvisoryCommittee.com.]...